Potential of Stem Cell-Based Therapy for Ischemic Stroke

Ischemic stroke is one of the major health problems worldwide. The only FDA approved anti-thrombotic drug for acute ischemic stroke is the tissue plasminogen activator. Several studies have been devoted to assessing the therapeutic potential of different types of stem cells such as neural stem cells...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Neurol
Autors principals: Marei, Hany E., Hasan, A., Rizzi, R., Althani, A., Afifi, N., Cenciarelli, C., Caceci, Thomas, Shuaib, Ashfaq
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808289/
https://ncbi.nlm.nih.gov/pubmed/29467713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.00034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars